bristol-myers glp-1 receptor agonist products Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Glucagon-like Peptide-1 Receptor Agonists (GLP-1

Koehler JA, Baggio LL, Yusta B, et al

Y., Chien, K

Critically, there is no substantial clinical evidence demonstrating that over-the-counter supplements can replicate the pharmacological effects of prescription GLP-1 receptor agonists

241 This mechanism is unaffected by genetic or pharmaceutical inhibition of GLP-1R, but it is sensitive to pertussis toxin

Therefore, the aim of the present study is to combine all available data on the safety of these medication classes during pregnancy and lactation

Gaining insight into the complex mechanisms through which GLP-1RAs produce their anti-inflammatory effects will improve our understanding of their therapeutic potential and facilitate the creation of new anti-inflammatory approaches